A family’s journey through the diagnosis and treatment of their baby girl, born with spinal muscular atrophy type 1…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Among people with spinal muscular atrophy (SMA) and other neuromuscular disorders, participation in adapted sports is associated with greater…
Problems with the secretion of survival signals from muscle cells seems to be the dominant driver of motor neuron loss…
The Muscular Dystrophy Association (MDA) is hosting an online Q&A session today to discuss the best ways that people…
As newborn screening for spinal muscular atrophy (SMA) becomes more common, ethical dilemmas will arise about the best treatment strategy…
Palliative care for babies with spinal muscular atrophy (SMA) type 1 has improved in recent decades, with greater involvement…
Preforming an imaging scan that uses less radiation can be used to plan the administration of Spinraza (nusinersen) in…
Risdiplam Data to New Way of Classifying ‘Types’ Among SMA Europe 2020 Highlights, Advocate Says
Results from a clinical trial of risdiplam in a broad range of people with spinal muscular…
The biopharmaceutical company Cytokinetics and the nonprofit organization Cure SMA have announced a renewal of their partnership. The…
Tina and Torence Anderson’s sixth and youngest child, Malachi, came into the world on July 31, 2015.